PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMisoprostol
Misoprostol
Arthrotec, Cytotec, Misoprostol (misoprostol) is a small molecule pharmaceutical. Misoprostol was first approved as Cytotec on 1988-12-27. The pharmaceutical is active against prostaglandin E2 receptor EP3 subtype. In addition, it is known to target prostaglandin E2 receptor EP2 subtype and prostaglandin E2 receptor EP4 subtype.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Cytotec (generic drugs available since 2002-07-10)
Combinations
Arthrotec (generic drugs available since 2002-07-10)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diclofenac sodium
+
Misoprostol
Tradename
Company
Number
Date
Products
ARTHROTECMylanN-020607 RX1997-12-24
2 products, RLD, RS
Misoprostol
Tradename
Company
Number
Date
Products
CYTOTECMylanN-019268 RX1988-12-27
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
arthrotecNew Drug Application2023-08-16
dicloenac sodium and misoprostolANDA2023-02-16
diclofenac sodium and misoprostolNDA authorized generic2023-08-15
diclofenac sodium misoprostolANDA2023-03-02
diclofenac sodium/misoprostolANDA2023-05-03
mpm pakANDA2023-06-13
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A02: Drugs for acid related disorders
— A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BB: Prostaglandin drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
— A02BB01: Misoprostol
G: Genito urinary system and sex hormones
— G02: Other gynecologicals in atc
— G02A: Uterotonics
— G02AD: Prostaglandins, oxytocics
— G02AD06: Misoprostol
M: Musculo-skeletal system drugs
— M01: Antiinflammatory and antirheumatic products
— M01A: Antiinflammatory and antirheumatic products, non-steroids
— M01AE: Propionic acid derivatives, antiinflammatory and antirheumatic products
— M01AE56: Naproxen and misoprostol
HCPCS
Code
Description
S0191
Misoprostol, oral, 200 mcg
Clinical
Clinical Trials
522 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Induced laborD007751——310892150
Postpartum hemorrhageD006473—O72179112349
PregnancyD011247EFO_0002950Z33.114691231
Induced abortionD000028———1361929
Cervical ripeningD020070———686323
Spontaneous abortionD000022EFO_1001255O00.1—6731022
Missed abortionD000030—O02.12639322
HemorrhageD006470MP_0001914R581353314
Incomplete abortionD000027EFO_1001799—1—111013
PainD010146EFO_0003843R522421210
Show 24 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pre-eclampsiaD011225EFO_0000668O14112—36
Uterine hemorrhageD014592————2—24
AnemiaD000740HP_0001903D64.9——1—12
Transient tachypnea of the newbornD059245—P22.1——1—12
InfertilityD007246HP_0000789——11——2
Labor painD048949————1—12
Atrial fibrillationD001281EFO_0000275I48.0——1——1
Myocardial ischemiaD017202EFO_1001375I20-I25——1——1
Peptic ulcer hemorrhageD010438———11——1
Stomach ulcerD013276—K25——1——1
Show 4 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Retained placentaD018457—O72.011——13
Clostridioides difficileD016360NCBITaxon_1496——1———1
First pregnancy trimesterD011261———1———1
Stem cell transplantationD033581———1———1
Hemorrhagic cystitisD000096722———1———1
Premature birthD047928EFO_0003917O60—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248HP_0002019K59.01————1
NauseaD009325HP_0002018R11.01————1
Morbid obesityD009767EFO_0001074—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_0000544—————11
High-risk pregnancyD018566——————11
Child developmentD002657——————11
Low back painD017116HP_0003419M54.5————11
Infant mortalityD007226——————11
Female infertilityD007247EFO_0008560N97————11
Intrauterine devicesD007434——————11
Postcoital contraceptionD044363——————11
Postoperative painD010149—G89.18————11
HysteroscopyD015907——————11
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMisoprostol
INNmisoprostol
Description
7-[(1R,2R,3R)-3-hydroxy-2-(4-hydroxy-4-methyloct-1-enyl)-5-oxocyclopentyl]heptanoic acid methyl ester is a prostanoid.
Classification
Small molecule
Drug classprostaglandins
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC
Identifiers
PDB—
CAS-ID59122-46-2
RxCUI—
ChEMBL IDCHEMBL606
ChEBI ID—
PubChem CID5282381
DrugBankDB00929
UNII ID0E43V0BB57 (ChemIDplus, GSRS)
Target
Agency Approved
PTGER3
PTGER3
Organism
Homo sapiens
Gene name
PTGER3
Gene synonyms
NCBI Gene ID
Protein name
prostaglandin E2 receptor EP3 subtype
Protein synonyms
PGE receptor, EP3 subtype, PGE2 receptor EP3 subtype, PGE2-R, prostaglandin E receptor 3 (subtype EP3), prostaglandin receptor (PGE-2), Prostanoid EP3 receptor
Uniprot ID
Mouse ortholog
Ptger3 (19218)
prostaglandin E2 receptor EP3 subtype (P30557)
Alternate
PTGER2
PTGER2
PTGER4
PTGER4
Organism
Homo sapiens
Gene name
PTGER2
Gene synonyms
NCBI Gene ID
Protein name
prostaglandin E2 receptor EP2 subtype
Protein synonyms
PGE receptor EP2 subtype, PGE2 receptor EP2 subtype, prostaglandin E receptor 2 (subtype EP2), 53kD, prostaglandin E receptor 2 (subtype EP2), 53kDa, Prostanoid EP2 receptor
Uniprot ID
Mouse ortholog
Ptger2 (19217)
prostaglandin E2 receptor EP2 subtype (Q62053)
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Arthrotec – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Misoprostol
+
Diclofenac
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Misoprostol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,438 documents
View more details
Safety
Black-box Warning
Black-box warning for: Arthrotec, Dicloenac sodium and misoprostol, Diclofenac sodium and misoprostol, Diclofenac sodium misoprostol, Diclofenac sodium/misoprostol, Mpm pak
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
9,067 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use